Maxigen Biotech Inc. (TPE:1783)

Taiwan · Delayed Price · Currency is TWD

42.95

0.00 (0.00%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biomedical Products	698.34M	644.57M	559.72M	414.87M	313.55M
Biomedical Products Growth	8.34%	15.16%	34.91%	32.32%	5.47%
Adjustment and Write-Off	-17.69M	-42.87M	-	-	-
Consumable Products	-	20.41M	44.71M	97.10M	144.14M
Consumable Products Growth	-	-54.34%	-53.95%	-32.63%	-6.95%
Total	680.65M	622.12M	604.43M	511.98M	457.69M
Total Growth	9.41%	2.93%	18.06%	11.86%	1.21%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Taiwan	298.86M	275.62M	245.23M	200.33M	189.68M
Taiwan Growth	8.43%	12.40%	22.41%	5.61%	6.36%
Asia	75.12M	95.82M	133.54M	90.54M	60.90M
Asia Growth	-21.60%	-28.25%	47.50%	48.68%	-21.08%
Others	51.13M	23.94M	5.89M	15.24M	19.03M
Others Growth	113.59%	306.59%	-61.37%	-19.89%	123.23%
America	196.57M	198.81M	189.63M	165.01M	147.97M
America Growth	-1.13%	4.84%	14.92%	11.52%	5.97%
Europe	58.98M	27.93M	30.15M	40.86M	40.13M
Europe Growth	111.19%	-7.38%	-26.21%	1.82%	-17.35%
Total	680.65M	622.12M	604.43M	511.98M	457.69M
Total Growth	9.41%	2.93%	18.06%	11.86%	1.21%

Source: S&P Global Market Intelligence.